Mayne Pharma
Chad Turner has extensive experience in the pharmaceutical industry, with a focus on women's health. Chad started their career in 2001 at Organon Pharmaceuticals, where they worked in the Women's Health department until 2003. Chad then joined Warner Chilcott as a Sales Manager before taking on roles as Marketing/Brand Manager, Director of Institutional Sales, and finally as Senior Manager in the Women's Health division. In 2014, Chad joined Eisai US as the Manager of Eisai Metabolics. Chad then moved to Mayne Pharma in 2016, where they held positions as Marketing Manager in the Generic Products division and as a National Account Executive in the Government Markets. Chad's most recent role, which they started in November 2019, is the Director of Sales Marketing in the Women's Health division at Mayne Pharma.
Chad Turner attended the University of West Florida from 1989 to 1993, where they pursued a degree in Business Administration with a focus on Finance and Management.
This person is not in any offices
Mayne Pharma
1 followers
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.